期刊文献+

醋酸奥曲肽在肠梗阻治疗中的临床效果观察 被引量:3

Clinical Effect of Octreotide Acetate in the Treatment of Intestinal Obstruction
下载PDF
导出
摘要 目的探究在肠梗阻治疗中应用醋酸奥曲肽的效果。方法 2014年1月—2017年1月收治46例肠梗阻患者展开本次研究,按照患者所接受的治疗方法不同将其分为对照组和观察组,对照组给予常规治疗,观察组则在常规治疗基础上加用醋酸奥曲肽;后对两组症状缓解时间、治疗效果等进行观察对比。结果观察组患者的症状缓解时间快于对照组、症状缓解率高于对照组,恶心、呕吐治疗的有效率82.61%(19/23)高于对照组52.17%(12/23),组间比较差异显著(P<0.05)。结论肠梗阻治疗中应用醋酸奥曲肽可有效改善患者各项症状,因此效果良好。 Objective To explore the effect of octreotide acetate in the treatment of intestinal obstruction.Methods From January 2014 to January 2017,46 patients were enrolled in this study.The patients were divided into control group and observation group.The control group was given routine treatment.The observation group was given the conventional treatment based on the use of octreotide acetate;After the two groups of symptom relief time,the treatment effect were observed and compared.Results The symptom relief time in the observation group was faster and the symptom relief rate was higher than that in the control group.The effective rate of nausea and vomiting treatment was 82.61%(19/23)in the observation group and 52.17%(12/23)in the control group.The difference was significant(P<0.05).Conclusion The application of octreotide acetate can effectively improve the symptoms of patients,so the effect is good.
作者 赵臣 杨英起 陈志东 孙宏文 ZHAO Chen;YANG Yingqi;CHEN Zhidong;SUN Hongwen(Department of Surgery,Baotou Medical College Third Affiliated Hospital,Baotou Inner Mongolia 014030,China)
出处 《中国卫生标准管理》 2018年第8期82-84,共3页 China Health Standard Management
关键词 肠梗阻 醋酸奥曲肽 临床效果 intestinal obstruction octreotide acetate clinical effect
  • 相关文献

参考文献8

二级参考文献51

  • 1宋景贵,毕洁亮,肖正英.莪术油腹腔灌注防治术后粘连性肠梗阻的临床研究[J].山东中医药大学学报,2004,28(6):432-435. 被引量:9
  • 2俞谦,孙为豪,刘顺英,欧希龙,曹大中,苏菡,江洁,俞婷.奥曲肽联合特异性COX-2抑制剂对肝癌细胞的抑制作用[J].东南大学学报(医学版),2005,24(6):363-367. 被引量:4
  • 3Klein C,Stiel S,Biikki J,et al.Pharmacological treatment of malignant bowel obstruction in severely ill and dying patients: a systematic literature review[J].Schmerz,2012,26(5):587-599.
  • 4Uchino R,Kusano S,Hanada N,et al.Clinical efficacy of octreotide acetate in cancer patients with malignant bowelsymptoms depend on terminal stage[J].Gan To Kagaku Ryoho,2011,38(2):255-257.
  • 5Davies DE,Wren T, MacLachlan SM.Octreotide infusion formalignant duodenal obstruction in a 12-year-old girl with metastatic peripheral nerve sheath mmor[J].J Pediatr Hematol Oncol,2012,34(7):e292-294.
  • 6Watari H, Hosaka M,Wakui Y, et al.A prospective study on the efficacy of oetreotide in the management of malignantbowel obstruction in gynecologic cancer[J]-Int J Gynecol Cancer,2012,22(4):692-696.
  • 7Mercadante S,Porzio G.Octreotide for malignant bowel obstruction twenty years after[J].Crit Rev Oncol Hematol,2012,83(3):388-392.
  • 8Laval G,Rousselot H,Toussaint-Martel S,et al.SALTO:a randomized,multicenter study assessing octreotide LAR in inoperable bowel obstruction[J].Bull Cancer,2012,99(2):E1-9.
  • 9Tanimura K,Onda S,Mitsunobu M.Effective made of octreotide intravenous administration for malignantgastrointestinal obstruction in terminal cancer patients[J].Gan To Kagaku Ryoho,2010,37(10):1991-1993.
  • 10中国抗癌协会癌症康复与姑息治疗专业委员会[c].晚期癌症患者合并肠梗阻治疗的专家共识(2008版):1—20.

共引文献26

同被引文献33

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部